Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics Inks Japan Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics today said that iPS Academia Japan will distribute the firm's iCell Cardiomyocytes in Japan.

Terms of the pact were not disclosed.

Cellular Dynamics was the first firm outside of Japan to receive a license to the induced pluripotent stem cell patent portfolio of Shinya Yamanaka, a member of iPS Academia Japan's scientific advisory board. iPS Academia Japan was established to manage the patents and technology arising from Yamanaka's research at Kyoto University.

Cellular Dyanmics, which was founded in 2004, also holds a license to iPSC technology stemming from work by University of Wisconsin at Madison stem cell researcher James Thomson, the company's founder and chief scientific officer.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.